Driven by patients,
guided by science
We support scientific research and outstanding care for cancer patients.
The Anticancer Fund is a Belgian non-profit organisation with an international scope. We depend fully on donations and private funding to finance our work.
We invest in the most promising research to make measurable progress in the fight against cancer.
We strive to improve survival and quality of life, financial return is not within the scope of our activities.
We identify untapped potential in cancer research leading to pragmatic solutions for patients in need.
We seek impact and we invest our resources where we believe we can make the most progress.
Every cancer deserves the same attention, regardless of prevalence or profitability.
In the news
Give young cancer patients more power!
September is Childhood Cancer Awareness Month, a time to highlight that children can also be diagnosed with cancer. We wrote a blog together with KickCancer, because the voice of the young patients must be heard.
Thinking out-of-the-box to fight braincancer: 10 drugs in 1 trial!
Glioblastoma is a very aggressive type of brain cancer. To tackle the issue, we combined 10 drugs in 1 trial.The first results of the trial are promising.
Personalised medicine: an opportunity or a threat?
The term ‘personalised medicine’ has become hip lately. But what’s it all about? And is personalised medicine really the way forward in treating cancer?
27 clinical studies in pancreatic cancer
We have received 27 applications to our call for projects in pancreatic and biliary tract cancer, announced earlier this year. The selection of the trials is expected at the end of the year.
Latest news about drug repurposing in oncology #9
Discover our latest newsletter with scientific updates and recent findings about the repurposing of generic drugs in oncology.
Non-cancer drugs increase survival in pancreatic cancer
The Anticancer Fund and the Cancer Registry of Norway have investigated the effects of different drugs on pancreatic cancer patients. The results, as reported in a new paper, show that patients treated with statins and non-selective beta blockers had better survival than patients not treated with those drugs.
WE MAKE A DIFFERENCE
We invest in researchWe put science to work for patients and we strive for short-term, meaningful impacts where they are most needed.
We set up clinical trialsWe are an independent, non-profit intermediary and focus on clinical research with limited economic value.
We connect peopleAs we are just a small part of the enormous cancer research ecosystem, we don't act alone.
We advise professionalsAccording to our mission and vision, we provide free advice in designing trials and reviewing scientific research.
We help cancer patientsWe personally answer therapy-related questions from patients and provide non-judgmental information.
Our current focus areas
Drug repurposingDrug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse of existing...
Less common and rare cancersWe don’t just focus on the ‘big four’ of cancer – prostate, colon, breast and lung. We also investigate new treatment...
Combination therapiesIt is important to investigate the impacts of drugs beyond what they can achieve alone. Using them in combination...
Preventing tumour recurrenceFor cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living...